You are here

  • Home
  • Archive
  • Volume 9, Issue 2
  • Integrative transcriptome analysis of malignant pleural mesothelioma reveals a clinically relevant immune-based classification

Article info

Article menu
XML
Clinical/translational cancer immunotherapy
Original research
Integrative transcriptome analysis of malignant pleural mesothelioma reveals a clinically relevant immune-based classification

Authors

  • Ania Alay Unit of Bioinformatics for Precision Oncology, Catalan Institute of Oncology (ICO)—Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain PubMed articlesGoogle scholar articles
  • David Cordero Unit of Bioinformatics for Precision Oncology, Catalan Institute of Oncology (ICO)—Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, SpainBiomedical Research Centre Network for Epidemiology & Public Health (CIBERESP), Madrid, Comunidad de Madrid, Spain PubMed articlesGoogle scholar articles
  • Sara Hijazo-Pechero Unit of Bioinformatics for Precision Oncology, Catalan Institute of Oncology (ICO)—Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Elisabet Aliagas Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Adriana Lopez-Doriga Unit of Bioinformatics for Precision Oncology, Catalan Institute of Oncology (ICO)—Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, SpainBiomedical Research Centre Network for Epidemiology & Public Health (CIBERESP), Madrid, Comunidad de Madrid, Spain PubMed articlesGoogle scholar articles
  • Raúl Marín Unit of Bioinformatics for Precision Oncology, Catalan Institute of Oncology (ICO)—Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Ramón Palmero Department of Medical Oncology, Catalan Institute of Oncology (ICO)—Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Roger Llatjós Department of Pathology, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Ignacio Escobar Department of Thoracic Surgery, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Ricard Ramos Department of Thoracic Surgery, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Susana Padrones Department of Respiratory Medicine, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Víctor Moreno Biomedical Research Centre Network for Epidemiology & Public Health (CIBERESP), Madrid, Comunidad de Madrid, SpainOncology Data Analytics Program, Catalan Institute of Oncology (ICO)—Bellvitge Biomedical Research Institute (IDIBELL)—University of Barcelona (UB), L'Hospitalet de Llobregat, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Ernest Nadal Department of Medical Oncology, Catalan Institute of Oncology (ICO)—Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Xavier Solé Unit of Bioinformatics for Precision Oncology, Catalan Institute of Oncology (ICO)—Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, SpainBiomedical Research Centre Network for Epidemiology & Public Health (CIBERESP), Madrid, Comunidad de Madrid, Spain PubMed articlesGoogle scholar articles

Citation

Alay A, Cordero D, Hijazo-Pechero S, et al
Integrative transcriptome analysis of malignant pleural mesothelioma reveals a clinically relevant immune-based classification
Journal for ImmunoTherapy of Cancer 2021;9:e001601. doi: 10.1136/jitc-2020-001601
Online issue publication 
January 26, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.